サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1251970

ガンマナイフの世界市場：脳腫瘍の流行が市場の成長を促進

Rising Prevalence of Brain Tumors Drives Growth in Gamma Knife Market
出版日: | 発行: Persistence Market Research | ページ情報: 英文 102 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ガンマナイフの世界市場：脳腫瘍の流行が市場の成長を促進
出版日: 2023年02月24日
発行: Persistence Market Research
ページ情報: 英文 102 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のガンマナイフ市場について調査分析し、市場動向、地域とセグメントごとの分析と予測、競合分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主な市場の動向

  • 市場に影響を与える主な動向
  • 製品のイノベーション/開発の動向

第4章 主な成功要因

  • 製品の採用/利用の分析
  • 製品のUSP/機能
  • インストールベースのシナリオ
  • 技術の評価
  • 規制情勢
  • PESTLE分析
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第5章 市場の背景

  • マクロ経済要因
    • 世界のGDP成長の見通し
    • 世界の医療の見通し
    • 世界の放射線治療市場の見通し
  • 予測要因 - 関連性と影響
    • 肥満の有病率
    • 非侵襲処置の需要
    • 増大する脳腫瘍の負担
    • 神経疾患の症例の増加
    • 新しい治療オプションの導入
    • 技術の進歩
    • 製品の採用率
    • インストールベースの拡大
  • 力学
    • 促進要因
    • 抑制要因
    • 機会の分析

第6章 COVID-19危機 - 影響の評価

  • COVID-19と影響の分析
    • 適応症別
    • 治療器官別
    • 地域別
  • 市場シナリオ（2022年）

第7章 世界市場の需要の分析と予測

  • 過去の市場の分析
  • 現在と将来の市場予測
    • 前年比成長動向の分析

第8章 世界市場の分析と予測：適応症別

  • イントロダクション/主な調査結果
  • 過去の市場の分析：適応症別
  • 現在と将来の市場の分析と予測：適応症別
    • 転移性脳腫瘍
    • がん
    • 脳動静脈奇形（AVM）
    • 三叉神経痛
    • その他
  • 市場魅力の分析：適応症別

第9章 世界市場の分析と予測：治療器官別

  • イントロダクション/主な調査結果
  • 過去の市場の分析：治療器官別
  • 現在と将来の市場の分析と予測：治療器官別
    • 頭
    • 首
    • その他
  • 市場魅力の分析：治療器官別

第10章 世界市場の分析と予測：地域別

  • イントロダクション
  • 過去の市場の分析：地域別
  • 現在と将来の市場の分析と予測：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力の分析：地域別

第11章 北米市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • 米国市場の分析
    • カナダ市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第12章 ラテンアメリカ市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • ブラジル市場の分析
    • メキシコ市場の分析
    • アルゼンチン市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第13章 欧州市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • ドイツ市場の分析
    • フランス市場の分析
    • イタリア市場の分析
    • 英国市場の分析
    • スペイン市場の分析
    • ロシア市場の分析
    • 北欧諸国市場の分析
    • ベネルクス市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第14章 南アジア市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • インド市場の分析
    • タイ市場の分析
    • インドネシア市場の分析
    • マレーシア市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第15章 東アジア市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • 中国市場の分析
    • 日本市場の分析
    • 韓国市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第16章 オセアニア市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • オーストラリア市場の分析
    • ニュージーランド市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第17章 中東・アフリカ市場の分析と予測

  • イントロダクション
  • 過去の市場の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 適応症別
    • 治療器官別
  • 市場魅力の分析
    • 国別
    • 適応症別
    • 治療器官別
  • 国レベルの分析と予測
    • GCC諸国市場の分析
    • トルコ市場の分析
    • 北アフリカ市場の分析
    • 南アフリカ市場の分析
  • 市場動向
  • 主な市場参入企業 - 強度マッピング
  • 促進要因と抑制要因 - 影響の分析

第18章 市場構造分析

  • 市場の分析：企業の階層別
  • 主要企業の市場シェアの分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合のベンチマーク
  • 競合の詳細
    • Elekta AB
    • Varian Medical Systems
    • Huiheng Medical, Inc.
    • MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
    • Akesis Inc.
    • Cyber Medical Corporation Limited.
    • Masep Infini Global, Inc.
    • Nordion, Inc.
    • Hokai
    • ET Medical Group
    • American Shared Hospital Services

第20章 使用される前提条件と頭字語

第21章 調査手法

図表

List of Tables

  • Table 01: Global Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 02: Global Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 03: Global Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 04: Global Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 05: Global Gamma Knife Historical Market Value (US$ Mn) Analysis, By Region 2017-2022
  • Table 06: Global Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Region, 2023-2033
  • Table 07: North America Gamma Knife Market Historical Market Value (US$ Mn) Analysis, By Country, 2017-2022
  • Table 08: North America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 09: North America Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 10: North America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 11: North America Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 12: North America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 13: Latin America Gamma Knife Market Historical Market Value (US$ Mn) Analysis, By Country, 2017-2022
  • Table 14: Latin America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 15: Latin America Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 16: Latin America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 17: Latin America Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 18: Latin America Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 19: Europe Gamma Knife Market Historical Market Value (US$ Mn) Analysis, By Country, 2017-2022
  • Table 20: Europe Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 21: Europe Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 22: Europe Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 23: Europe Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 24: Europe Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 25: South Asia Gamma Knife Market Historical Market Value (US$ Mn) Analysis, By Country, 2017-2022
  • Table 26: South Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 27: South Asia Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 28: South Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 29: South Asia Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 30: South Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 31: East Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2017-2022
  • Table 32: East Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 33: East Asia Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 34: East Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 35: East Asia Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 36: East Asia Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 37: Oceania Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2017-2022
  • Table 38: Oceania Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 39: Oceania Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 40: Oceania Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 41: Oceania Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 42: Oceania Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033
  • Table 43: Middle East and Africa Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2017-2022
  • Table 44: Middle East and Africa Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 45: Middle East and Africa Gamma Knife Historical Market Value (US$ Mn) Analysis, By Disease Indication, 2017-2022
  • Table 46: Middle East and Africa Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Disease Indication, 2023-2033
  • Table 47: Middle East and Africa Gamma Knife Historical Market Value (US$ Mn) Analysis, By Organ Treated, 2017-2022
  • Table 48: Middle East and Africa Gamma Knife Current and Future Market Size (US$ Mn) Analysis, By Organ Treated, 2023-2033

List of Figures

  • Figure 01: Global Gamma Knife Market (US$ Mn) Historical Analysis, 2017-2022
  • Figure 02: Global Gamma Knife Market Value (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 03: Global Gamma Knife Market Absolute $ Opportunity, 2023-2033
  • Figure 04: Global Gamma Knife Market Share Analysis (%) By Disease Indication, 2023 & 2033
  • Figure 05: Global Gamma Knife Market Y-o-Y Growth (%) By Disease Indication, 2023-2033
  • Figure 06: Global Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 07: Global Gamma Knife Market Share Analysis (%) By Organ Treated, 2023 & 2033
  • Figure 08: Global Gamma Knife Market Y-o-Y Growth (%) By Organ Treated, 2023-2033
  • Figure 09: Global Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 10: Global Gamma Knife Market Share Analysis (%) By Region, 2023 & 2033
  • Figure 11: Global Gamma Knife Market Y-o-Y Growth (%) By Region, 2023-2033
  • Figure 12: Global Gamma Knife Market Attractiveness Analysis, By Region
  • Figure 13: North America Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 14: North America Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 15: North America Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 16: North America Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 17: North America Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 18: North America Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 19: North America Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 20: U.S. Market Value Proportion Analysis, 2023
  • Figure 21: Global Vs U.S. Y-o-Y Growth Comparison, 2022-2033
  • Figure 22: U.S. Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 23: U.S. Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 24: Canada Market Value Proportion Analysis, 2023
  • Figure 25: Global Vs Canada Y-o-Y Growth Comparison, 2022-2033
  • Figure 26: Canada Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 27: Canada Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 28: Latin America Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 29: Latin America Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 30: Latin America Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 31: Latin America Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 32: Latin America Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 33: Latin America Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 34: Latin America Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 35: Brazil Market Value Proportion Analysis, 2023
  • Figure 36: Global Vs Brazil Y-o-Y Growth Comparison, 2022-2033
  • Figure 37: Brazil Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 38: Brazil Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 39: Mexico Market Value Proportion Analysis, 2023
  • Figure 40: Global Vs Mexico Y-o-Y Growth Comparison, 2022-2033
  • Figure 41: Mexico Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 42: Mexico Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 43: Argentina Market Value Proportion Analysis, 2023
  • Figure 44: Global Vs Argentina Y-o-Y Growth Comparison, 2022-2033
  • Figure 45: Argentina Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 46: Argentina Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 47: Europe Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 48: Europe Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 49: Europe Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 50: Europe Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 51: Europe Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 52: Europe Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 53: Europe Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 54: U.K. Market Value Proportion Analysis, 2023
  • Figure 55: Global Vs U.K. Y-o-Y Growth Comparison, 2022-2033
  • Figure 56: U.K. Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 57: U.K. Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 58: Germany Market Value Proportion Analysis, 2023
  • Figure 59: Global Vs Germany Y-o-Y Growth Comparison, 2022-2033
  • Figure 60: Germany Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 61: Germany Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 62: Italy Market Value Proportion Analysis, 2023
  • Figure 63: Global Vs Italy Y-o-Y Growth Comparison, 2022-2033
  • Figure 64: Italy Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 65: Italy Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 66: France Market Value Proportion Analysis, 2023
  • Figure 67: Global Vs France Y-o-Y Growth Comparison, 2022-2033
  • Figure 68: France Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 69: France Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 70: Spain Market Value Proportion Analysis, 2023
  • Figure 71: Global Vs Spain Y-o-Y Growth Comparison, 2022-2033
  • Figure 72: Spain Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 73: Spain Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 74: Russia Market Value Proportion Analysis, 2023
  • Figure 75: Global Vs Russia Y-o-Y Growth Comparison, 2022-2033
  • Figure 76: Russia Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 77: Russia Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 78: Nordic Countries Market Value Proportion Analysis, 2023
  • Figure 79: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2022-2033
  • Figure 80: Nordic Countries Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 81: Nordic Countries Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 82: BENELUX Market Value Proportion Analysis, 2023
  • Figure 83: Global Vs BENELUX Y-o-Y Growth Comparison, 2022-2033
  • Figure 84: BENELUX Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 85: BENELUX Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 86: South Asia Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 87: South Asia Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 88: South Asia Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 89: South Asia Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 90: South Asia Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 91: South Asia Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 92: South Asia Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 93: India Market Value Proportion Analysis, 2023
  • Figure 94: Global Vs India Y-o-Y Growth Comparison, 2022-2033
  • Figure 95: India Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 96: India Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 97: Thailand Market Value Proportion Analysis, 2023
  • Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2022-2033
  • Figure 99: Thailand Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 100: Thailand Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 101: Indonesia Market Value Proportion Analysis, 2023
  • Figure 102: Global Vs Indonesia Y-o-Y Growth Comparison, 2022-2033
  • Figure 103: Indonesia Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 104: Indonesia Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 105: Malaysia Market Value Proportion Analysis, 2023
  • Figure 106: Global Vs Malaysia Y-o-Y Growth Comparison, 2022-2033
  • Figure 107: Malaysia Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 108: Malaysia Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 109: East Asia Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 110: East Asia Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 111: East Asia Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 112: East Asia Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 113: East Asia Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 114: East Asia Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 115: East Asia Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 116: China Market Value Proportion Analysis, 2023
  • Figure 117: Global Vs China Y-o-Y Growth Comparison, 2022-2033
  • Figure 118: China Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 119: China Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 120: Japan Market Value Proportion Analysis, 2023
  • Figure 121: Global Vs Japan Y-o-Y Growth Comparison, 2022-2033
  • Figure 122: Japan Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 123: Japan Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 124: South Korea Market Value Proportion Analysis, 2023
  • Figure 125: Global Vs South Korea Y-o-Y Growth Comparison, 2022-2033
  • Figure 126: South Korea Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 127: South Korea Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 128: Oceania Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 129: Oceania Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 130: Oceania Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 131: Oceania Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 132: Oceania Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 133: Oceania Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 134: Oceania Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 135: Australia Market Value Proportion Analysis, 2023
  • Figure 136: Global Vs Australia Y-o-Y Growth Comparison, 2022-2033
  • Figure 137: Australia Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 138: Australia Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 139: New Zealand Market Value Proportion Analysis, 2023
  • Figure 140: Global Vs New Zealand Y-o-Y Growth Comparison, 2022-2033
  • Figure 141: New Zealand Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 142: New Zealand Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 143: Middle East and Africa (MEA) Gamma Knife Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 144: Middle East and Africa (MEA) Gamma Knife Market Value (US$ Mn) Analysis, By Disease Indication, 2023
  • Figure 145: Middle East and Africa Gamma Knife Historical Market (US$ Mn) Analysis, 2017-2022
  • Figure 146: Middle East and Africa Gamma Knife Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 147: Middle East and Africa Gamma Knife Market Attractiveness Analysis, By Country
  • Figure 148: Middle East and Africa Gamma Knife Market Attractiveness Analysis, By Disease Indication
  • Figure 149: Middle East and Africa Gamma Knife Market Attractiveness Analysis, By Organ Treated
  • Figure 150: GCC Countries Market Value Proportion Analysis, 2023
  • Figure 151: Global Vs GCC Countries Y-o-Y Growth Comparison, 2022-2033
  • Figure 152: GCC Countries Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 153: GCC Countries Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 154: Turkiye Market Value Proportion Analysis, 2023
  • Figure 155: Global Vs Turkiye Y-o-Y Growth Comparison, 2022-2033
  • Figure 156: Turkiye Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 157: Turkiye Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 158: North Africa Market Value Proportion Analysis, 2023
  • Figure 159: Global Vs North Africa Y-o-Y Growth Comparison, 2022-2033
  • Figure 160: North Africa Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 161: North Africa Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
  • Figure 162: South Africa Market Value Proportion Analysis, 2023
  • Figure 163: Global Vs South Africa Y-o-Y Growth Comparison, 2022-2033
  • Figure 164: South Africa Gamma Knife Market Share Analysis (%) By Disease Indication, 2022 & 2033
  • Figure 165: South Africa Gamma Knife Market Share Analysis (%) by Organ Treated, 2022 & 2033
目次
Product Code: PMRREP3742

Gamma Knife Market: Scope of the Report

The latest publication by Persistence Market Research on the global gamma knife market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for gamma knife systems and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the gamma knife market. Shareholders in the gamma knife market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the gamma knife market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the gamma knife market offers information divided into six important segments - disease indication, organ treated, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Disease Indication

Brain Metastasis

Cancer

Arteriovenous Malformation (AVM)

Trigeminal Neuralgia

Others

Organ Treated

Head

Neck

Others

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for gamma knife over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the gamma knife market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the gamma knife market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the gamma knife market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Install Base Scenario
  • 4.4. Technology Assessment
  • 4.5. Regulatory Landscape
  • 4.6. PESTLE Analysis
  • 4.7. Porter Analysis
  • 4.8. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Radiotherapy Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Obesity
    • 5.2.2. Demand for Non-Invasive Procedures
    • 5.2.3. Growing Burden of Brain Cancer
    • 5.2.4. Increasing Instances of Neurological Disorders
    • 5.2.5. Introduction of Novel Treatment Options
    • 5.2.6. Technological Advancements
    • 5.2.7. Product Adoption Rate
    • 5.2.8. Growing Installed Base
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Disease Indication
    • 6.1.2. By Organ Treated
    • 6.1.3. By Region
  • 6.2. 2022 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Disease Indication

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2017-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2023-2033
    • 8.3.1. Brain Metastasis
    • 8.3.2. Cancer
    • 8.3.3. Arteriovenous Malformation (AVM)
    • 8.3.4. Trigeminal Neuralgia
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis By Disease Indication

9. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Organ Treated

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Organ Treated, 2017-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ Treated, 2023-2033
    • 9.3.1. Head
    • 9.3.2. Neck
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis By Organ Treated

10. Global Market Analysis 2017-2022 and Forecast 2023-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2017-2022 and Forecast 2023-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Disease Indication
    • 11.3.3. By Organ Treated
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Disease Indication
    • 11.4.3. By Organ Treated
  • 11.5. Country Level Analysis & Forecast
    • 11.5.1. U.S. Market Analysis
      • 11.5.1.1. Introduction
      • 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.1.2.1. By Disease Indication
        • 11.5.1.2.2. By Organ Treated
    • 11.5.2. Canada Market Analysis
      • 11.5.2.1. Introduction
      • 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.2.2.1. By Disease Indication
        • 11.5.2.2.2. By Organ Treated
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2017-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Disease Indication
    • 12.3.3. By Organ Treated
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Disease Indication
    • 12.4.3. By Organ Treated
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. Brazil Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Disease Indication
        • 12.5.1.2.2. By Organ Treated
    • 12.5.2. Mexico Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Disease Indication
        • 12.5.2.2.2. By Organ Treated
    • 12.5.3. Argentina Market Analysis
      • 12.5.3.1. Introduction
      • 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.3.2.1. By Disease Indication
        • 12.5.3.2.2. By Organ Treated
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2017-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. BENELUX
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Disease Indication
    • 13.3.3. By Organ Treated
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Disease Indication
    • 13.4.3. By Organ Treated
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Germany Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Disease Indication
        • 13.5.1.2.2. By Organ Treated
    • 13.5.2. France Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Disease Indication
        • 13.5.2.2.2. By Organ Treated
    • 13.5.3. Italy Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Disease Indication
        • 13.5.3.2.2. By Organ Treated
    • 13.5.4. U.K. Market Analysis
      • 13.5.4.1. Introduction
      • 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.4.2.1. By Disease Indication
        • 13.5.4.2.2. By Organ Treated
    • 13.5.5. Spain Market Analysis
      • 13.5.5.1. Introduction
      • 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.5.2.1. By Disease Indication
        • 13.5.5.2.2. By Organ Treated
    • 13.5.6. Russia Market Analysis
      • 13.5.6.1. Introduction
      • 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.6.2.1. By Disease Indication
        • 13.5.6.2.2. By Organ Treated
    • 13.5.7. Nordic Countries Market Analysis
      • 13.5.7.1. Introduction
      • 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.7.2.1. By Disease Indication
        • 13.5.7.2.2. By Organ Treated
    • 13.5.8. BENELUX Market Analysis
      • 13.5.8.1. Introduction
      • 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.8.2.1. By Disease Indication
        • 13.5.8.2.2. By Organ Treated
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2017-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Thailand
      • 14.3.1.3. Indonesia
      • 14.3.1.4. Malaysia
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Disease Indication
    • 14.3.3. By Organ Treated
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Disease Indication
    • 14.4.3. By Organ Treated
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. India Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Disease Indication
        • 14.5.1.2.2. By Organ Treated
    • 14.5.2. Thailand Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Disease Indication
        • 14.5.2.2.2. By Organ Treated
    • 14.5.3. Indonesia Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Disease Indication
        • 14.5.3.2.2. By Organ Treated
    • 14.5.4. Malaysia Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Disease Indication
        • 14.5.4.2.2. By Organ Treated
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2017-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Disease Indication
    • 15.3.3. By Organ Treated
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Disease Indication
    • 15.4.3. By Organ Treated
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. China Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Disease Indication
        • 15.5.1.2.2. By Organ Treated
    • 15.5.2. Japan Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Disease Indication
        • 15.5.2.2.2. By Organ Treated
    • 15.5.3. South Korea Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Disease Indication
        • 15.5.3.2.2. By Organ Treated
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2017-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Disease Indication
    • 16.3.3. By Organ Treated
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Disease Indication
    • 16.4.3. By Organ Treated
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Australia Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Disease Indication
        • 16.5.1.2.2. By Organ Treated
    • 16.5.2. New Zealand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Disease Indication
        • 16.5.2.2.2. By Organ Treated
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Disease Indication
    • 17.3.3. By Organ Treated
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Disease Indication
    • 17.4.3. By Organ Treated
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. GCC Countries Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Disease Indication
        • 17.5.1.2.2. By Organ Treated
    • 17.5.2. Turkiye Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Disease Indication
        • 17.5.2.2.2. By Organ Treated
    • 17.5.3. Northern Africa Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Disease Indication
        • 17.5.3.2.2. By Organ Treated
    • 17.5.4. South Africa Market Analysis
      • 17.5.4.1. Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Disease Indication
        • 17.5.4.2.2. By Organ Treated
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Elekta AB
      • 19.3.1.1. Overview
      • 19.3.1.2. Disease Indication Portfolio
      • 19.3.1.3. Key Financials
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. SWOT Analysis
      • 19.3.1.6. Strategy Overview
        • 19.3.1.6.1. Marketing Strategy
        • 19.3.1.6.2. Product Strategy
        • 19.3.1.6.3. Channel Strategy
    • 19.3.2. Varian Medical Systems
      • 19.3.2.1. Overview
      • 19.3.2.2. Disease Indication Portfolio
      • 19.3.2.3. Key Financials
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. SWOT Analysis
      • 19.3.2.6. Strategy Overview
        • 19.3.2.6.1. Marketing Strategy
        • 19.3.2.6.2. Product Strategy
        • 19.3.2.6.3. Channel Strategy
    • 19.3.3. Huiheng Medical, Inc.
      • 19.3.3.1. Overview
      • 19.3.3.2. Disease Indication Portfolio
      • 19.3.3.3. Key Financials
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. SWOT Analysis
      • 19.3.3.6. Strategy Overview
        • 19.3.3.6.1. Marketing Strategy
        • 19.3.3.6.2. Product Strategy
        • 19.3.3.6.3. Channel Strategy
    • 19.3.4. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
      • 19.3.4.1. Overview
      • 19.3.4.2. Disease Indication Portfolio
      • 19.3.4.3. Key Financials
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. SWOT Analysis
      • 19.3.4.6. Strategy Overview
        • 19.3.4.6.1. Marketing Strategy
        • 19.3.4.6.2. Product Strategy
        • 19.3.4.6.3. Channel Strategy
    • 19.3.5. Akesis Inc.
      • 19.3.5.1. Overview
      • 19.3.5.2. Disease Indication Portfolio
      • 19.3.5.3. Key Financials
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. SWOT Analysis
      • 19.3.5.6. Strategy Overview
        • 19.3.5.6.1. Marketing Strategy
        • 19.3.5.6.2. Product Strategy
        • 19.3.5.6.3. Channel Strategy
    • 19.3.6. Cyber Medical Corporation Limited.
      • 19.3.6.1. Overview
      • 19.3.6.2. Disease Indication Portfolio
      • 19.3.6.3. Key Financials
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. SWOT Analysis
      • 19.3.6.6. Strategy Overview
        • 19.3.6.6.1. Marketing Strategy
        • 19.3.6.6.2. Product Strategy
        • 19.3.6.6.3. Channel Strategy
    • 19.3.7. Masep Infini Global, Inc.
      • 19.3.7.1. Overview
      • 19.3.7.2. Disease Indication Portfolio
      • 19.3.7.3. Key Financials
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. SWOT Analysis
      • 19.3.7.6. Strategy Overview
        • 19.3.7.6.1. Marketing Strategy
        • 19.3.7.6.2. Product Strategy
        • 19.3.7.6.3. Channel Strategy
    • 19.3.8. Nordion, Inc.
      • 19.3.8.1. Overview
      • 19.3.8.2. Disease Indication Portfolio
      • 19.3.8.3. Key Financials
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. SWOT Analysis
      • 19.3.8.6. Strategy Overview
        • 19.3.8.6.1. Marketing Strategy
        • 19.3.8.6.2. Product Strategy
        • 19.3.8.6.3. Channel Strategy
    • 19.3.9. Hokai
      • 19.3.9.1. Overview
      • 19.3.9.2. Disease Indication Portfolio
      • 19.3.9.3. Key Financials
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. SWOT Analysis
      • 19.3.9.6. Strategy Overview
        • 19.3.9.6.1. Marketing Strategy
        • 19.3.9.6.2. Product Strategy
        • 19.3.9.6.3. Channel Strategy
    • 19.3.10. ET Medical Group
      • 19.3.10.1. Overview
      • 19.3.10.2. Disease Indication Portfolio
      • 19.3.10.3. Key Financials
      • 19.3.10.4. Sales Footprint
      • 19.3.10.5. SWOT Analysis
      • 19.3.10.6. Strategy Overview
        • 19.3.10.6.1. Marketing Strategy
        • 19.3.10.6.2. Product Strategy
        • 19.3.10.6.3. Channel Strategy
    • 19.3.11. American Shared Hospital Services
      • 19.3.11.1. Overview
      • 19.3.11.2. Disease Indication Portfolio
      • 19.3.11.3. Key Financials
      • 19.3.11.4. Sales Footprint
      • 19.3.11.5. SWOT Analysis
      • 19.3.11.6. Strategy Overview
        • 19.3.11.6.1. Marketing Strategy
        • 19.3.11.6.2. Product Strategy
        • 19.3.11.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology